BioMS Medical to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference |
|
By: BioMS Medical Corp. Posted: 2007-10-31 05:28:28 |
|
BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Kevin Giese, President and CEO, will present at the Acumen BioFin Rodman and Renshaw 9th Annual Healthcare Conference in New York.
WHEN: Monday, November 5th at 3:20 pm (Local Time) WHERE: New York Palace Hotel, New York About Acumen BioFin Rodman and Renshaw 9th Annual Healthcare Conference ----------------------------------------------------------------------- The Conference will include presentations by over 350 companies, as well as experts from the medical, scientific and investment communities. The Conference will be attended by investors, venture capitalists, company executives, scientists and other industry leaders. For more information visit http://www.rodmanandrenshaw.com/ About BioMS Medical Corp. ------------------------- BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. For further information please visit our website at http://www.biomsmedical.com. This news release may contain certain forward-looking statements that reflect the current views and/or expectations of BioMS Medical with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly. |
| Trackback url: https://press.abc-directory.com/press/2215 |